1-9 of 9
Julie M. Cherrington
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CCR 20th Anniversary Commentary: Determining a Pharmacokinetic/Pharmacodynamic Relationship for Sunitinib—A Look Back

Dirk B. Mendel, Julie M. Cherrington, A. Douglas Laird
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (11): 2415–2417.
https://doi.org/10.1158/1078-0432.CCR-14-2557
Published: 31 May 2015
View articletitled, CCR 20th Anniversary Commentary: Determining a Pharmacokinetic/Pharmacodynamic Relationship for Sunitinib—A Look Back
Open the PDF for CCR 20th Anniversary Commentary: Determining a Pharmacokinetic/Pharmacodynamic Relationship for Sunitinib—A Look Back in another window
Journal Articles

An Innovative Phase I Clinical Study Demonstrates Inhibition of FLT3 Phosphorylation by SU11248 in Acute Myeloid Leukemia Patients

Anne-Marie O’Farrell, James M. Foran, Walter Fiedler, Hubert Serve, Ron L. Paquette, Maureen A. Cooper, Helene A. Yuen, Sharianne G. Louie, Heidi Kim, Susan Nicholas, Michael C. Heinrich, Wolfgang E. Berdel, Carlo Bello, Mark Jacobs, Paul Scigalla, William C. Manning, Stephen Kelsey, Julie M. Cherrington
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (15): 5465–5476.
Published: 03 December 2003
View articletitled, An Innovative Phase I Clinical Study Demonstrates Inhibition of FLT3 Phosphorylation by SU11248 in Acute Myeloid Leukemia Patients
Open the PDF for An Innovative Phase I Clinical Study Demonstrates Inhibition of FLT3 Phosphorylation by SU11248 in Acute Myeloid Leukemia Patients in another window
Journal Articles

Proof of Target for SU11654: Inhibition of KIT Phosphorylation in Canine Mast Cell Tumors

Nancy K. Pryer, Leslie B. Lee, Regina Zadovaskaya, Xiaoming Yu, Juthamas Sukbuntherng, Julie M. Cherrington, Cheryl A. London
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (15): 5729–5734.
Published: 03 December 2003
View articletitled, Proof of Target for SU11654: Inhibition of KIT Phosphorylation in Canine Mast Cell Tumors
Open the PDF for Proof of Target for SU11654: Inhibition of KIT Phosphorylation in Canine Mast Cell Tumors in another window
Journal Articles

The Combination of the Tyrosine Kinase Receptor Inhibitor SU6668 with Paclitaxel Affects Ascites Formation and Tumor Spread in Ovarian Carcinoma Xenografts Growing Orthotopically

Angela Garofalo, Elitza Naumova, Luigi Manenti, Carmen Ghilardi, Gabriele Ghisleni, Mario Caniatti, Tina Colombo, Julie M. Cherrington, Eugenio Scanziani, Maria Ines Nicoletti, Raffaella Giavazzi
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (9): 3476–3485.
Published: 05 September 2003
View articletitled, The Combination of the Tyrosine Kinase Receptor Inhibitor SU6668 with Paclitaxel Affects Ascites Formation and Tumor Spread in Ovarian Carcinoma Xenografts Growing Orthotopically
Open the PDF for The Combination of the Tyrosine Kinase Receptor Inhibitor SU6668 with Paclitaxel Affects Ascites Formation and Tumor Spread in Ovarian Carcinoma Xenografts Growing Orthotopically in another window
Journal Articles

Phase I Dose-Escalating Study of SU11654, a Small Molecule Receptor Tyrosine Kinase Inhibitor, in Dogs with Spontaneous Malignancies

Cheryl A. London, Alison L. Hannah, Regina Zadovoskaya, May B. Chien, Cynthia Kollias-Baker, Mona Rosenberg, Sue Downing, Gerald Post, Joseph Boucher, Narmada Shenoy, Dirk B. Mendel, Gerald McMahon, Julie M. Cherrington
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (7): 2755–2768.
Published: 01 July 2003
View articletitled, Phase I Dose-Escalating Study of SU11654, a Small Molecule Receptor Tyrosine Kinase Inhibitor, in Dogs with Spontaneous Malignancies
Open the PDF for Phase I Dose-Escalating Study of SU11654, a Small Molecule Receptor Tyrosine Kinase Inhibitor, in Dogs with Spontaneous Malignancies in another window
Journal Articles

In Vivo Antitumor Activity of SU11248, a Novel Tyrosine Kinase Inhibitor Targeting Vascular Endothelial Growth Factor and Platelet-derived Growth Factor Receptors: Determination of a Pharmacokinetic/Pharmacodynamic Relationship

Dirk B. Mendel, A. Douglas Laird, Xiaohua Xin, Sharianne G. Louie, James G. Christensen, Guangmin Li, Randall E. Schreck, Tinya J. Abrams, Theresa J. Ngai, Leslie B. Lee, Lesley J. Murray, Jeremy Carver, Emily Chan, Katherine G. Moss, Joshua Ö. Haznedar, Juthamas Sukbuntherng, Robert A. Blake, Li Sun, Cho Tang, Todd Miller, Sheri Shirazian, Gerald McMahon, Julie M. Cherrington
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (1): 327–337.
Published: 01 January 2003
View articletitled, In Vivo Antitumor Activity of SU11248, a Novel Tyrosine Kinase Inhibitor Targeting Vascular Endothelial Growth Factor and Platelet-derived Growth Factor Receptors: Determination of a Pharmacokinetic/Pharmacodynamic Relationship
Open the PDF for In Vivo Antitumor Activity of SU11248, a Novel Tyrosine Kinase Inhibitor Targeting Vascular Endothelial Growth Factor and Platelet-derived Growth Factor Receptors: Determination of a Pharmacokinetic/Pharmacodynamic Relationship in another window
Journal Articles

High Levels of HER-2 Expression Alter the Ability of Epidermal Growth Factor Receptor (EGFR) Family Tyrosine Kinase Inhibitors to Inhibit EGFR Phosphorylation in Vivo

James G. Christensen, Randall E. Schreck, Emily Chan, Xueyan Wang, Chris Yang, Luna Liu, Jean Cui, Li Sun, James Wei, Julie M. Cherrington, Dirk B. Mendel
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (12): 4230–4238.
Published: 01 December 2001
View articletitled, High Levels of HER-2 Expression Alter the Ability of Epidermal Growth Factor Receptor (EGFR) Family Tyrosine Kinase Inhibitors to Inhibit EGFR Phosphorylation in Vivo
Open the PDF for High Levels of HER-2 Expression Alter the Ability of Epidermal Growth Factor Receptor (EGFR) Family Tyrosine Kinase Inhibitors to Inhibit EGFR Phosphorylation in Vivo in another window
Journal Articles

The Angiogenesis Inhibitor SU5416 Has Long-lasting Effects on Vascular Endothelial Growth Factor Receptor Phosphorylation and Function

Dirk B. Mendel, Randall E. Schreck, David C. West, Guangmin Li, Laurie M. Strawn, Sheila S. Tanciongco, Stefan Vasile, Laura K. Shawver, Julie M. Cherrington
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (12): 4848–4858.
Published: 01 December 2000
View articletitled, The Angiogenesis Inhibitor SU5416 Has Long-lasting Effects on Vascular Endothelial Growth Factor Receptor Phosphorylation and Function
Open the PDF for The Angiogenesis Inhibitor SU5416 Has Long-lasting Effects on Vascular Endothelial Growth Factor Receptor Phosphorylation and Function in another window
Journal Articles

Effects of SU101 in Combination with Cytotoxic Agents on the Growth of Subcutaneous Tumor Xenografts

Laurie M. Strawn, Fairooz Kabbinavar, Donna P. Schwartz, Elaina Mann, Laura K. Shawver, Dennis J. Slamon, Julie M. Cherrington
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (7): 2931–2940.
Published: 01 July 2000
View articletitled, Effects of SU101 in Combination with Cytotoxic Agents on the Growth of Subcutaneous Tumor Xenografts
Open the PDF for Effects of SU101 in Combination with Cytotoxic Agents on the Growth of Subcutaneous Tumor Xenografts in another window